Cited by 450Prion Diseases and Protein MisfoldingAlzheimer's disease research and treatmentsAmyotrophic Lateral Sclerosis Research

The DOI matches its Crossref record; 153 of the 154 references it cites were found in a registry or an index.

Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases

Open access

Jucker, Mathias, Walker, Lary C.·2018·Nature Neuroscience

DOI 10.1038/s41593-018-0238-6PMC PMC6375686

Open this paper in CoChat — free account

Abstract

Many neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis, are characterized by the progressive appearance of abnormal proteinaceous assemblies in the nervous system. Studies in experimental systems indicate that the assemblies originate from the prion-like seeded aggregation of specific misfolded proteins that proliferate and amass to form the intracellular and/or extracellular lesions typical of each disorder. The host in which the proteopathic seeds arise provides the biochemical and physiological environment that either supports or restricts their emergence, proliferation, self-assembly, and spread. Multiple mechanisms influence the spatiotemporal spread of seeds and the nature of the resulting lesions, one of which is the cellular uptake, release, and transport of seeds along neural pathways and networks. The characteristics of cells and regions in the affected network govern their vulnerability and thereby influence the neuropathological and clinical attributes of the disease. The propagation of pathogenic protein assemblies within the nervous system is thus determined by the interaction of the proteopathic agent and the host milieu.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41593-018-0238-6

Cites

153 of 153 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Novel Proteinaceous Infectious Particles Cause Scrapie
Prusiner, S. B. (1982) · Science · doi:10.1126/science.6801762 · Cited by 5,221
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
An Essay on the Shaking Palsy
Parkinson, J. (2002) · Journal of Neuropsychiatry · doi:10.1176/jnp.14.2.223 · Cited by 2,856
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
The spectrum of disease in chronic traumatic encephalopathy
McKee, A. C., Stein, T. D., Nowinski, C. J., Stern, R. A., Daneshvar, D. H., Alvarez, V. E., Lee, H.-S., Hall, G., Wojtowicz, S. M., Baugh, C. M., et al. (2013) · Brain · doi:10.1093/brain/aws307 · Cited by 2,098
Cryo-EM structures of tau filaments from Alzheimer’s disease
Fitzpatrick, A. W. P., Falcon, B., He, S., Murzin, A. G., Murshudov, G., Garringer, H. J., Crowther, R. A., Ghetti, B., Goedert, M., & Scheres, S. H. W. (2017) · Nature · doi:10.1038/nature23002 · Cited by 2,061

Show all 154 references

Sorted by citations

Items 101–200 of 442

Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy body disease
Spencer, B. J., Trinh, I., Rockenstein, E. M., Mante, M., Florio, J. B., Adame, A., El‐Agnaf, O. M. A., Kim, C., Masliah, E., & Rissman, R. A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.03.001 · Cited by 48
Neuropathology of the Alzheimer's continuum: an update
Jellinger, K. A. (2020) · Free Neuropathology · doi:10.17879/freeneuropathology-2020-3050 · Cited by 52
Peptide–Protein Interactions: From Drug Design to Supramolecular Biomaterials
Caporale, A., Adorinni, S., Lamba, D., & Saviano, M. (2021) · Molecules · doi:10.3390/molecules26051219 · Cited by 45
Transmission of amyloid-beta and tau pathologies is associated with cognitive impairments in a primate
Lam, S., Petit, F., Hérard, A., Boluda, S., Eddarkaoui, S., Guillermier, M., The Brain Bank Neuro-C. E. B. Neuropathology Network, Letournel, F., Martin‐Négrier, M., Faisant, M., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01266-8 · Cited by 45
The Role of Antibodies and Their Receptors in Protection Against Ordered Protein Assembly in Neurodegeneration
Katsinelos, T., Tuck, B. J., Mukadam, A. S., & McEwan, W. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01139 · Cited by 46
The interplay of biochemical and biomechanical degeneration in Alzheimer’s disease
Schäfer, A., Weickenmeier, J., & Ellen Kuhl, A. (2019) · Computer Methods in Applied Mechanics and Engineering · doi:10.1016/j.cma.2019.04.028 · Cited by 43
Exosomal and vesicle‐free tau seeds—propagation and convergence in endolysosomal permeabilization
Polanco, J. C., & Götz, J. (2021) · FEBS Journal · doi:10.1111/febs.16055 · Cited by 43
Local structural preferences in shaping tau amyloid polymorphism
Louros, N. N., Wilkinson, M., Tsaka, G., Ramakers, M., Morelli, C., Garcia, T., Gallardo, R. U., D’Haeyer, S., Goossens, V., Audenaert, D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45429-2 · Cited by 42
Global brain activity and its coupling with cerebrospinal fluid flow is related to tau pathology
Han, F., Lee, J., Chen, X., Ziontz, J., Ward, T. J., Landau, S. M., Baker, S. L., Harrison, T. M., Jagust, W. J., & Initiative, A. D. N. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14296 · Cited by 42
An update on the association between traumatic brain injury and Alzheimer’s disease: Focus on Tau pathology and synaptic dysfunction
Li, L., Liang, J., & Fu, H. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.10.020 · Cited by 42
Disrupting pathologic phase transitions in neurodegeneration
Hurtle, B. T., Xie, L., & Donnelly, C. J. (2023) · Journal of Clinical Investigation · doi:10.1172/jci168549 · Cited by 40
Inflammation and Parkinson's disease pathogenesis: Mechanisms and therapeutic insight
Forloni, G., Vitola, P. L., Cerovic, M., & Balducci, C. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.11.001 · Cited by 41
Wolframin is a novel regulator of tau pathology and neurodegeneration
Chen, S., Acosta, D. M., Li, L., Liang, J., Chang, Y., Wang, C., Fitzgerald, J., Morrison, C. T., Goulbourne, C. N., Nakano, Y., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02417-4 · Cited by 40
Current insights and assumptions on α-synuclein in Lewy body disease
Leak, R. K., Clark, R. N., Abbas, M., Xu, F., Brodsky, J. L., Chen, J., Hu, X., & Luk, K. C. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02781-3 · Cited by 41
Gut Microbiota and Immune System Dynamics in Parkinson’s and Alzheimer’s Diseases
Kuštrimović, N. Z., Balkhi, S., Bilato, G., & Mortara, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212164 · Cited by 39
α-Synuclein aggregation and transmission in Parkinson’s disease: a link to mitochondria and lysosome
Wang, R., Sun, H., Ren, H., & Wang, G. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1756-9 · Cited by 38
Single‐Molecule Characterization and Super‐Resolution Imaging of Alzheimer's Disease‐Relevant Tau Aggregates in Human Samples
Böken, D., Cox, D., Burke, M., Lam, J. Y. L., Katsinelos, T., Danial, J. S. H., Fertan, E., McEwan, W. A., Rowe, J. B., & Klenerman, D. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202317756 · Cited by 38
Application of yeast to studying amyloid and prion diseases
Chernoff, Y. O., Grizel, A. V., Rubel, A. A., Zelinsky, A. А., Chandramowlishwaran, P., & Chernova, T. A. (2020) · Advances in genetics · doi:10.1016/bs.adgen.2020.01.002 · Cited by 41
α-Synuclein Strains: Does Amyloid Conformation Explain the Heterogeneity of Synucleinopathies?
Hoppe, S. O., Uzunoğlu, G., & Nussbaum-Krammer, C. I. (2021) · Biomolecules · doi:10.3390/biom11070931 · Cited by 37
Praja1 RING ‐finger E3 ubiquitin ligase suppresses neuronal cytoplasmic TDP ‐43 aggregate formation
Watabe, K., Kato, Y., Sakuma, M., Murata, M., Niida‐Kawaguchi, M., Takemura, T., Hanagata, N., Tada, M., Kakita, A., & Shibata, N. (2020) · Neuropathology · doi:10.1111/neup.12694 · Cited by 37
Improving and fine-tuning the properties of peptide-based hydrogels via incorporation of peptide nucleic acids
Giraud, T., Bouguet‐Bonnet, S., Marchal, P., Pickaert, G., Averlant‐Petit, M., & Stefan, L. (2020) · Nanoscale · doi:10.1039/d0nr03483e · Cited by 36
The chaperone Clusterin in neurodegeneration−friend or foe?
Yuste‐Checa, P., Bracher, A., & Hartl, F. U. (2022) · BioEssays · doi:10.1002/bies.202100287 · Cited by 37
Prion neurotoxicity
Le, N. T. T., Wu, B., & Harris, D. A. (2018) · Brain Pathology · doi:10.1111/bpa.12694 · Cited by 36
Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases
Liu, J., Ting, J. P., Al-Azzam, S., Ding, Y., & Afshar, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062805 · Cited by 37
Nanopolyphenol rejuvenates microglial surveillance of multiple misfolded proteins through metabolic reprogramming
Wang, D., Gu, X. Q., Ma, X., Chen, J., Zhang, Q., Yu, Z., Li, J., Meng, H., Tan, X., Tang, Y., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.07.014 · Cited by 35
Microglial inclusions and neurofilament light chain release follow neuronal α-synuclein lesions in long-term brain slice cultures
Barth, M., Bacioglu, M., Schwarz, N., Novotny, R., Brandes, J., Welzer, M., Mazzitelli, S., Häsler, L. M., Schweighauser, M., Wuttke, T. V., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00471-2 · Cited by 35
Self-citation
Modulating the aggregation of amyloid proteins by macrocycles
Gao, L., & Li, Y. (2022) · Aggregate · doi:10.1002/agt2.161 · Cited by 34
Alzheimer’s disease: From basic science to precision medicine approach
Forloni, G. (2020) · BMJ Neurology Open · doi:10.1136/bmjno-2020-000079 · Cited by 33
Role of Glia-Derived Extracellular Vesicles in Neurodegenerative Diseases
Li, T., Tan, X., Li, S., Al-Nusaif, M., & Le, W. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.765395 · Cited by 33
PET imaging of microglia in Alzheimer's disease using copper-64 labeled TREM2 antibodies
Shojaei, M., Schaefer, R., Schlepckow, K., Kunze, L. H., Struebing, F. L., Brunner, B., Willem, M., Bartos, L. M., Feiten, A., Palumbo, G., et al. (2024) · Theranostics · doi:10.7150/thno.97149 · Cited by 35
Strategies and materials of "SMART" non-viral vectors: Overcoming the barriers for brain gene therapy
Li, Y., Liu, L., Ji, W., Peng, H., Zhao, R., & Zhang, X. (2020) · Nano Today · doi:10.1016/j.nantod.2020.101006 · Cited by 34
BACE1-dependent cleavage of GABAA receptor contributes to neural hyperexcitability and disease progression in Alzheimer’s disease
Bi, D., Bao, H., Yang, X., Wu, Z., Yang, X., Xu, G., Liu, X., Wan, Z., Liu, J., He, J., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.01.030 · Cited by 32
Clinical relevance of brain atrophy subtypes categorization in memory clinics
Planche, V., Bouteloup, V., Mangin, J., Dubois, B., Delrieu, J., Pasquier, F., Blanc, F., Paquet, C., Hanon, O., Gabelle, A., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12231 · Cited by 32
Toll-like Receptor 4 Is Upregulated in Parkinson’s Disease Patients and Co-Localizes with pSer129αSyn: A Possible Link with the Pathology
Conte, C., Ingrassia, A. M. T., Brevé, J. J. P., Bol, J. G. J. M., Huisman, E., van Dam, A., Beccari, T., & van de Berg, W. D. J. (2023) · Cells · doi:10.3390/cells12101368 · Cited by 33
Intercellular communication in the brain through a dendritic nanotubular network
Chang, M., Krüssel, S., Parajuli, L. K., Kim, J., Lee, D., Merodio, A., Kwon, J., Okabe, S., & Kwon, H. (2025) · Science · doi:10.1126/science.adr7403 · Cited by 32
Advanced neuroimaging approaches in amyotrophic lateral sclerosis: refining the clinical diagnosis
Kassubek, J., & Müller, H. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1715798 · Cited by 31
Piezoelectric nanogenerators enabled neuromodulation rescued dopaminergic neuron loss in Parkinson’s disease
Chen, Y., Feng, P., Zhong, G., Liu, J., Jiang, B., Harn, Y., Zhao, D. S., Lin, Z., Zhang, Q., & Shen, Q. (2023) · Nano Energy · doi:10.1016/j.nanoen.2023.109187 · Cited by 31
Lack of Causal Associations of Inflammatory Bowel Disease with Parkinson's Disease and Other Neurodegenerative Disorders
Zeng, R., Wang, J., Zheng, C., Jiang, R., Tong, S., Wu, H., Zhuo, Z., Yang, Q., Leung, F. W., Sha, W., et al. (2023) · Movement Disorders · doi:10.1002/mds.29386 · Cited by 30
A dynamical systems approach for multiscale synthesis of Alzheimer’s pathogenesis
Rollo, J. L., Crawford, J. W., & Hardy, J. (2023) · Neuron · doi:10.1016/j.neuron.2023.04.018 · Cited by 31
Disease modification in Parkinsonism: obstacles and ways forward
Höllerhage, M., Klietz, M., & Höglinger, G. U. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02520-6 · Cited by 29
Recent Developments in Positron Emission Tomography Tracers for Proteinopathies Imaging in Dementia
Ni, R., & Nitsch, R. M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.751897 · Cited by 30
Experimental evidence for temporal uncoupling of brain Aβ deposition and neurodegenerative sequelae
Rother, C., Uhlmann, R. E., Müller, S. A., Schelle, J., Skodras, A., Obermüller, U., Häsler, L. M., Lambert, M., Baumann, F., Xu, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34538-5 · Cited by 28
Self-citation
Thy1-ApoE4/C/EBPβ double transgenic mice act as a sporadic model with Alzheimer’s disease
Qian, Z., Wang, Z., Li, B., Meng, X., Kuang, Z., Li, Y., Yang, Y., & Ye, K. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02565-x · Cited by 28
Dietary Gluten and Neurodegeneration: A Case for Preclinical Studies
Mohan, M., Okeoma, C. M., & Sestak, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155407 · Cited by 30
Prionoids in amyotrophic lateral sclerosis
Gosset, P., Camu, W., Raoul, C., & Mezghrani, A. (2022) · Brain Communications · doi:10.1093/braincomms/fcac145 · Cited by 31
Yeast Models for Amyloids and Prions: Environmental Modulation and Drug Discovery
Chernova, T. A., Chernoff, Y. O., & Wilkinson, K. D. (2019) · Molecules · doi:10.3390/molecules24183388 · Cited by 29
Reciprocal Regulation of Chaperone-Mediated Autophagy/Microautophagy and Exosome Release
Oshima, M., Seki, T., Kurauchi, Y., Hisatsune, A., & Katsuki, H. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00316 · Cited by 27
Flanking regions, amyloid cores, and polymorphism: the potential interplay underlying structural diversity
Bhopatkar, A. A., & Kayed, R. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105122 · Cited by 28
Research Progress of Microbiota-Gut-Brain Axis in Parkinson's Disease
Zhang, W., Ye, Y., Song, J., Sang, T., Xia, T., Xie, L., Qiu, X., Zeng, Q., & Luo, X. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2206157 · Cited by 30
In vivo detection of Alzheimer's and Lewy body disease concurrence: Clinical implications and future perspectives
Baiardi, S., Hansson, O., Levin, J., & Parchi, P. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14039 · Cited by 27
Drosophila as a Model for Microbiota Studies of Neurodegeneration
Kitani‐Morii, F., Friedland, R. P., Yoshida, H., & Mizuno, T. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215031 · Cited by 31
Docking and Molecular Dynamics-Based Identification of Interaction between Various Beta-Amyloid Isoforms and RAGE Receptor
Tolstova, A. P., Adzhubei, A. A., Mitkevich, V. A., Petrushanko, I. Y., & Makarov, A. А. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911816 · Cited by 26
Amyloid Signaling in Filamentous Fungi and Bacteria
Saupe, S. J. (2020) · Annual Review of Microbiology · doi:10.1146/annurev-micro-011320-013555 · Cited by 26
A bifunctional probe that allows dual-channel fluorescence turn-on detection of protein aggregates and hydrogen peroxide in neurodegenerative diseases
Ma, J., Wang, X., Li, N., & Cheng, Y. (2021) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2021.130536 · Cited by 25
Effect of β-amyloid on blood-brain barrier properties and function
Petrushanko, I. Y., Mitkevich, V. A., & Makarov, A. А. (2023) · Biophysical Reviews · doi:10.1007/s12551-023-01052-x · Cited by 28
Microbial amyloids in neurodegenerative amyloid diseases
Sampson, T. R. (2023) · FEBS Journal · doi:10.1111/febs.17023 · Cited by 25
Exploring Alzheimer's disease: a comprehensive brain connectome-based survey
Zhang, L., Qu, J., Ma, H., Chen, T., Liu, T., & Zhu, D. (2024) · Psychoradiology · doi:10.1093/psyrad/kkad033 · Cited by 27
Chronic administration of prebiotics and probiotics ameliorates pathophysiological hallmarks of Alzheimer’s disease in a APP/PS1 transgenic mouse model
Lana, D., Traini, C., Bulli, I., Sarti, G., Magni, G., Attorre, S., Giovannini, M. G., & Vannucchi, M. G. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1451114 · Cited by 27
Open questions on the nature of Parkinson’s disease: from triggers to spreading pathology
Mou, L., Ding, W., & Fernández-Fúnez, P. (2019) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2019-106210 · Cited by 28
Selective neuronal vulnerability in Alzheimer’s disease
Wang, Z.-T., Zhang, C. M., Wang, Y., Dong, Q., Tan, L., & Yu, J. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101114 · Cited by 24
Atrophy in behavioural variant frontotemporal dementia spans multiple large-scale prefrontal and temporal networks
Eldaief, M. C., Brickhouse, M. J., Katsumi, Y., Rosen, H. J., Carvalho, N., Touroutoglou, A., & Dickerson, B. C. (2023) · Brain · doi:10.1093/brain/awad167 · Cited by 25
Metabolic dysfunction and mitochondrial failure in Alzheimer's disease: integrating pathophysiology, clinical evidence and emerging interventions
Xiao, X., Yan, X., Liang, C., & Yang, Y. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1772036 · Cited by 25
Mitochondrial Protein Import Dysfunction in Pathogenesis of Neurodegenerative Diseases
Goyal, S., & Chaturvedi, R. K. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02200-0 · Cited by 25
Comprehensive profiling of bioactive compounds in germinated black soybeans via UHPLC-ESI-QTOF-MS/MS and their anti-Alzheimer’s activity
Shabbir, U., Tyagi, A., Ham, H.-J., & Oh, D. (2022) · PLoS ONE · doi:10.1371/journal.pone.0263274 · Cited by 23
Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation?
Engelender, S., Stefanis, L., Oddo, S., & Bellucci, A. (2022) · Movement Disorders · doi:10.1002/mds.29058 · Cited by 23
Thiophene‐Based Ligands: Design, Synthesis and Their Utilization for Optical Assignment of Polymorphic‐Disease‐Associated Protein Aggregates
Björk, L., Klingstedt, T., & Nilsson, K. P. R. (2023) · ChemBioChem · doi:10.1002/cbic.202300044 · Cited by 24
The G51D SNCA mutation generates a slowly progressive α-synuclein strain in early-onset Parkinson’s disease
Lau, H. H. C., Martínez-Valbuena, I., So, R. W. L., Mehra, S., Silver, N. R. G., Mao, A., Stuart, E., Schmitt-Ulms, C., Hyman, B. T., Ingelsson, M., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01570-5 · Cited by 25
C-reactive protein: the nexus between inflammation and protein misfolding diseases
Roy, A., Zeller, J., Nero, T. L., Klepetko, J., Eisenhardt, S. U., Parker, M. W., McFadyen, J. D., & Peter, K. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1612703 · Cited by 23
Braiding Braak and Braak: Staging patterns and model selection in network neurodegeneration
Putra, P. S., Thompson, T., Chaggar, P., Goriely, A., & Initiative, F. T. A. D. N. (2021) · Network Neuroscience · doi:10.1162/netn_a_00208 · Cited by 25
Prion protein and prion disease at a glance
Zhu, C., & Aguzzi, A. (2021) · Journal of Cell Science · doi:10.1242/jcs.245605 · Cited by 27
Neurodegenerative Diseases and Cholesterol: Seeing the Field Through the Players
Pfrieger, F. W. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.766587 · Cited by 22
Hyperphosphorylated Tau Inflicts Intracellular Stress Responses that Are Mitigated by Apomorphine
Song, Z., Wang, K., Hagar, H. C., Chen, H., Kuan, C.-Y., Zhang, K., & Kuo, M. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03689-x · Cited by 23
Modeling neurodegeneration in chronic traumatic encephalopathy using gradient damage models
Noël, L., & Ellen Kuhl, A. (2019) · Computational Mechanics · doi:10.1007/s00466-019-01717-z · Cited by 22
Snca -GFP Knock-In Mice Reflect Patterns of Endogenous Expression and Pathological Seeding
Caputo, A., Liang, Y., Raabe, T. D., Lo, A., Horvath, M., Zhang, B., Brown, H. J., Stieber, A., & Luk, K. C. (2020) · eNeuro · doi:10.1523/eneuro.0007-20.2020 · Cited by 22
Tau assemblies do not behave like independently acting prion-like particles in mouse neural tissue
Mukadam, A. S., Miller, L. V. C., Durrant, C. S., Vaysburd, M. J., Katsinelos, T., Tuck, B. J., Sanford, S., Sheppard, O., Knox, C., Cheng, S., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01141-6 · Cited by 23
Acquired cerebral amyloid angiopathy: An emerging concept
Yamada, M., Hamaguchi, T., & Sakai, K. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.05.012 · Cited by 21
The prion protein and its ligands: Insights into structure-function relationships
Shafiq, M., Vela, S. D., Amin, L., Younas, N., Harris, D. A., Zerr, I., Altmeppen, H. C., Svergun, D. I., & Glatzel, M. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119240 · Cited by 21
Praja1 RING ‐finger E3 ubiquitin ligase is a common suppressor of neurodegenerative disease‐associated protein aggregation
Watabe, K., Niida‐Kawaguchi, M., Tada, M., Kato, Y., Murata, M., Tanji, K., Wakabayashi, K., Yamada, M., Kakita, A., & Shibata, N. (2022) · Neuropathology · doi:10.1111/neup.12840 · Cited by 21
Structural Mimicry in Microbial and Antimicrobial Amyloids
Golan, N., Engelberg, Y., & Landau, M. (2022) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-032620-105157 · Cited by 21
Transgenic Mouse Models for the Study of Neurodegenerative Diseases
Marín‐Moreno, A., Canoyra, S., Fernández‐Borges, N., Espinosa, J. C., & Torres, J. M. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2801021 · Cited by 21
Switching On/Off Amyloid Plaque Formation in Transgenic Animal Models of Alzheimer’s Disease
Kozin, S. A., Kechko, O. I., Adzhubei, A. A., Makarov, A. А., & Mitkevich, V. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010072 · Cited by 21
Adding intrinsically disordered proteins to biological ageing clocks
Dormann, D., & Lemke, E. A. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01423-w · Cited by 23
Amyloid-β modulates the phase separation and aggregation of α-synuclein
Röntgen, A., Toprakcioglu, Z., Morris, O. M., & Vendruscolo, M. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2501987122 · Cited by 20
Innovative Non-PrP-Targeted Drug Strategy Designed to Enhance Prion Clearance
Baldeschi, A. C., Zattoni, M., Vanni, S., Nikolić, L., Ferracin, C., Sala, G. L., Summa, M., Bertorelli, R., Bertozzi, S. M., Giachin, G., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00205 · Cited by 20
Hunting for the cause: Evidence for prion-like mechanisms in Huntington’s disease
Donnelly, K. M., Coleman, C. M., Fuller, M. L., Reed, V. L., Smerina, D., Tomlinson, D. S., & Pearce, M. M. P. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.946822 · Cited by 20
The MuSK agonist antibody protects the neuromuscular junction and extends the lifespan in C9orf72-ALS mice
Sun, S., Shen, Y., Zhang, X., Ding, N., Xu, Z., Zhang, Q., & Li, L. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.05.016 · Cited by 19
The Process of Amyloid Formation due to Monoclonal Immunoglobulins
Morgan, G. J., & Wall, J. S. (2020) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2020.07.003 · Cited by 19
Matrin3: Disorder and ALS Pathogenesis
Salem, A., Wilson, C. J., Rutledge, B. S., Dilliott, A. A., Farhan, S. M. K., Choy, W., & Duennwald, M. L. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.794646 · Cited by 20
Plant-Based Inhibitors of Protein Aggregation
Zhytniakivska, O. A., Chaturvedi, T., & Thomsen, M. H. (2025) · Biomolecules · doi:10.3390/biom15040481 · Cited by 18
Current Understanding of Protein Aggregation in Neurodegenerative Diseases
Hu, C., Lin, M., Wang, C., & Zhang, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110568 · Cited by 21
Photobiomodulation and visual stimulation against cognitive decline and Alzheimer's disease pathology: A systematic review
Monteiro, F., Carvalho, Ó. S. N., Sousa, N., Silva, F. S., & Sotiropoulos, I. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12249 · Cited by 20
The Role of Clearance in Neurodegenerative Diseases
Brennan, G. S., Thompson, T., Oliveri, H., Rognes, M. E., & Goriely, A. (2023) · SIAM Journal on Applied Mathematics · doi:10.1137/22m1487801 · Cited by 20
Polyphenolic Compounds: Orchestrating Intestinal Microbiota Harmony during Aging
Pereira, Q. C., Fortunato, I. M., Oliveira, F. D. S., Alvarez, M. C., dos Santos, T. W., & Ribeiro, M. L. (2024) · Nutrients · doi:10.3390/nu16071066 · Cited by 19
Intercellular Transmission of a Synthetic Bacterial Cytotoxic Prion-Like Protein in Mammalian Cells
Revilla-García, A., Fernández, C., Álamo, M. M., Rı́os, V. D. L., Vorberg, I. M., & Giraldo, R. (2020) · mBio · doi:10.1128/mbio.02937-19 · Cited by 18
Biophysical studies of protein misfolding and aggregation in in vivo models of Alzheimer's and Parkinson's diseases
Sinnige, T., Stroobants, K., Dobson, C. M., & Vendruscolo, M. (2020) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583520000025 · Cited by 18
The HSPB1-p62/SQSTM1 functional complex regulates the unconventional secretion and transcellular spreading of the HD-associated mutant huntingtin protein
Bonavita, R., Scerra, G., Martino, R. D., Nuzzo, S., Polishchuk, E., Gennaro, M. D., Williams, S. V., Caporaso, M. G., Caiazza, C., Polishchuk, R., et al. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad047 · Cited by 18
Personalised regional modelling predicts tau progression in the human brain
Chaggar, P., Vogel, J. W., Binette, A. P., Thompson, T., Strandberg, O. T., Mattsson, N., Karlsson, L., Stomrud, E., Jbabdi, S., Magon, S., et al. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003241 · Cited by 19
α-Synuclein aggregates inhibit ESCRT-III through sequestration and collateral degradation
Sitron, C. S., Trinkaus, V. A., Galesic, A., Garhammer, M., Yuste‐Checa, P., Dransfeld, U., Feigenbutz, D., Zhang, J., Ivashko, L., Dudanova, I., et al. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.08.022 · Cited by 19
The Gut-Brain Axis in Alzheimer’s Disease: Exploring Microbial Influences and Therapeutic Strategies
Mustafa, M. A., Vadia, N., Varma, P., Al‐Shaker, H., Mohanty, B., Dhyani, A., Kaur, I., Chauhan, A. S., & Garg, G. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05474-4 · Cited by 18
Metal homeostasis disturbances in neurodegenerative disorders, with special emphasis on Creutzfeldt-Jakob disease – Potential pathogenetic mechanism and therapeutic implications
Nakagawa, Y., & Yamada, S. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107455 · Cited by 18

Authors: Jucker, M., & Walker, L. C.
Affiliations: German Center for Neurodegenerative Diseases (DE)
Emory University (US)
Corresponding author: Jucker, Mathias
Walker, Lary C.
ORCID: Jucker, Mathias
Walker, Lary C.
Venue: Nature Neuroscience
Publisher: Springer Science and Business Media LLC
Published: 2018-09-26
Volume: 21
Issue: 10
Pages: 1341-1349
ISSN: 1097-6256 (ISSN-L)
1546-1726
DOI: 10.1038/s41593-018-0238-6
PMC: PMC6375686
OpenAlex: W2891544369
Cited by: 450
References: 154
Citations by year: 2026: 50 · 2025: 69 · 2024: 41 · 2023: 59 · 2022: 51 · 2021: 70 · 2020: 66 · 2019: 40 · 2018: 4
FWCI: 4.41
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature Neuroscience (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
DZNE Pub (submittedVersion)
Funders: National Institutes of Health (P51OD011132)
National Institute on Aging (P50AG025688)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords: neurodegenerative diseases, protein aggregation, prion-like seeding, protein misfolding, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, seed propagation, neurodegeneration, host-pathogen interaction
MeSH terms: Animals, Cell Communication, Humans, Prions, Neurodegenerative Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks